Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive statistically significant results from the 8-week (extended from four ...

The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

As the CBSE Class 12 Chemistry exam nears, teachers stress that success depends on calm reasoning, smart time management, and ...

In addition to supporting heart health and weight management, lentils can help you meet your daily goals of protein and fiber. Here's what to know about the benefits of these legumes—and how to ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will participate in and sponsor the 10 th Annual MASH-TAG ...

Want to stay on top of your wellness in 2026? These are the trends you need to know about, according to industry experts.

Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, ...

Gregory D. Gorgas, Chief Executive Officer of Artelo, added, “ART12.11 was purpose-built to meet the standards required for federal healthcare integration and prescription-based use, and we believe it ...

Throughout 2025, CancerVax achieved substantial scientific progress, expanded its leadership and intellectual property portfolio, and advanced the development of its AI-engineered "Smart mRNA" and ...

Common HIV and cancer medications damage brain cell functions (lipid imbalance), contributing to cognitive decline. Need for ...

Aβ and tau get much of the glory in Alzheimer’s disease, but the disease is far more complex than two proteins. Scientists know, for example, that lipid metabolism goes awry, but identifying ...